Ειδήσεις: BIOTECH | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 19:36 yahoo.com

Jim Cramer on ImmunityBio: “I Would Encourage You to Own It, Provided You Don’t Own Any Other Spec”

Jim Cramer ImmunityBio stock recommendation biotech investment advice diversification

31/03 19:28 yahoo.com

Why Agios Pharmaceuticals Stock Is Up More Than 21% Today

Agios Pharmaceuticals stock surge biotech oncology pipeline clinical trial partnership

31/03 18:06 yahoo.com

RBC Capital Cuts PT on Legend Biotech Corporation (LEGN) to $62 From $66 – Here’s Why

RBC Capital Legend Biotech price target earnings valuation regulatory approvals

31/03 18:06 yahoo.com

Wells Fargo Lifts PT on Liquidia Corporation (LQDA) to $51 From $44 – Here’s Why

Wells Fargo Liquidia price target biotech earnings outlook product pipeline

31/03 18:06 yahoo.com

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now

Alnylam RNAi high‑growth biotech healthcare stocks gene therapy

31/03 18:06 yahoo.com

Mizuho Lifts PT on BridgeBio Pharma (BBIO) to $106 From $91 – Here’s Why

BridgeBio Pharma Mizuho price target pipeline positive trial data strategic partnerships

31/03 18:06 yahoo.com

Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why

Insmed Stifel price target earnings outlook pipeline stock upgrade

31/03 18:06 yahoo.com

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why

BioNTech BMO Capital price target vaccine demand earnings outlook competition

31/03 18:00 statnews.com

STAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor

gene editing FDA regulation custom therapies rare diseases manufacturing challenges Baby KJ

31/03 18:00 statnews.com

STAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor

gene editing FDA regulation custom therapies rare diseases manufacturing challenges Baby KJ

Loading...